MedPath

Apathy in Parkinson Disease: Clinical, Physiopathological and Pharmacological Study

Conditions
Apathy in Parkinson Disease
Registration Number
NCT01020682
Lead Sponsor
University Hospital, Grenoble
Brief Summary

Apathy has been reported to occur after subthalamic nucleus stimulation (STN-DBS), a treatment of motor complications in advanced Parkinson's disease (PD). It is not known whether postoperative apathy is related to dopamine withdrawal or a side effect of STN DBS. The researchers investigated potential predictors of apathy, and the effect of dopamine agonist treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Parkinson disease
Exclusion Criteria
  • Mattis scale < 130
  • Beck scale > 20

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hopital neurologique

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath